University of Rochester Department of Otolaryngology Head and Neck Surgery
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Man, Li-Xing
NCT06188871: Early-onset Dupilumab Effects in CRSwNP

Withdrawn
4
5
US
Dupilumab, Dupixent
University of Rochester
Chronic Rhinosinusitis With Nasal Polyps
06/26
06/27
ANCHOR-1, NCT05274750 / 2021-005037-16: Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Hourglass Jul 2024 - Dec 2024 : Acceptance of regulatory submission in US for CRSwNP
Completed
3
276
Europe, Canada, Japan, US, RoW
Depemokimab (GSK3511294), Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Nasal Polyps
07/24
08/24
Allen, Paul
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Recruiting
3
120
US
OPN-375
Optinose US Inc.
Bilateral Nasal Polyposis
03/26
03/26
NCT04142697: Human Visual and Vestibular Motion Perception Study

Recruiting
N/A
300
US
Heading direction adaptation
University of Rochester, National Institute on Deafness and Other Communication Disorders (NIDCD)
Vestibular Disease
09/26
09/27
POCD, NCT05378659: Neuroinflammation and Alzheimer's Pathology in

Recruiting
N/A
120
US
Montreal Cognitive Assessment, MOCA, Stroop Test, 4AT Delirium, Grooved Pegboard, NACC Cognitive Battery, ERP Testing, Blood Plasma and Serum sampling, Cerebral Spinal Fluid Sample
University of Tennessee Graduate School of Medicine, Alzheimer's Association
Post-Operative Confusion, Neuroinflammatory Response, Alzheimer Disease
06/22
09/22

Download Options